ViralGains, Inc., the leading marketing platform specializing in zero-party data and AI-powered audience-building solutions, today announced the grant of U.S. Patent No. 12,437,319 B2 by the United States Patent and Trademark Office. This grant expands the company’s foundational intellectual property in AI-powered media intelligence.

The patent protects the core system that enables the ViralGains platform to continuously learn from real-time consumer feedback. It covers the technology that uses creative and interaction signals to determine the best audience for an ad and to drive delivery of that ad - essential capabilities that empower brands to stop wasting impressions and start delivering outcomes on the open web, in-app, mobile and connected TV.

This innovation arrives as the advertising industry faces a dual crisis: not just "signal loss" from fading identifiers, but a scramble for high-quality data. As AI becomes central to all marketing, tech players and brands are discovering that unverified, assumed data is the single biggest bottleneck to impact and efficiency. ViralGains’ patented system directly answers this call, providing the "Consumer Intelligence Layer" that turns advertising into an engine for consented Zero-Party Data – the "good data" essential for fueling AI models and making the open web a viable, high-performance alternative to walled gardens.

“This patent solidifies our AI and data leadership in the new era of advertising,” said Tod Loofbourrow, CEO of ViralGains. “As advertising becomes increasingly AI and data driven, brands are hungry for engines of consented consumer intention to build high-performance predictive AI models that prioritize privacy, safety, and accuracy and measurably drive business outcomes.”

“We are building the Consumer Intelligence Layer brands can trust, and this patent is a core blueprint,” said Safaa Lafnoune, VP of Product at ViralGains. “The patent protects the technology that allows brands to instantly reduce wasted impressions and drive outcomes. These patented capabilities are a key part of our AI flywheel, reflected in our VoiceAlike® engine, which produces the high-intent, predictive audiences that marketers can activate anywhere across the open web.”

This patented, AI-driven approach is already delivering massive, quantifiable lift for the world’s top brands, including up to a 3x improvement in qualified patient reach for pharmaceutical campaigns and 71% higher click-through rates versus traditional third-party data baselines.